Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

EFTRW EFFECTOR THERAPEUTICS INC C/WTS 31/12/2025 (TO PUR COM)

Watchlist
0.180
-0.017-8.63%
Close  02/08 16:00 ET
High
0.180
Open
0.150
Turnover
3.49K
Low
0.124
Pre Close
0.197
Volume
23.11K
Market Cap
0
P/E(TTM)
0.00
52wk High
0.580
Shares
0
P/E(Static)
0.00
52wk Low
0.036
Float Cap
0
Bid/Ask %
100.00%
Historical High
2.490
Shs Float
0
Volume Ratio
2.24
Historical Low
0.036
Dividend TTM
--
Div Yield TTM
--
P/B
0.00
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.00%
Amplitude
28.57%
Avg Price
0.150
Lot Size
1
Float Cap
0
Bid/Ask %
100.00%
Historical High
2.490
Shs Float
0
Volume Ratio
2.24
Historical Low
0.036
Dividend TTM
--
P/B
0.00
Dividend LFY
--
Turnover Ratio
0.00%
Amplitude
28.57%
Avg Price
0.150
Lot Size
1
Price Forecast

News

Comment

No More
Company Overview More
eFFECTOR Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development of a new class oncology drugs known as selective translation regulator inhibitors (STRIs). Its STRI product candidates target the eIF4F complex and its activating kinase, mitogen-activated protein kinase 1/2 (MNK 1/2). The company was founded by Kevan Shokat, Davide Ruggero, and Siegfried Reich on May 1, 2012 and is headquartered in San Diego, CA.
CEO: Dr. Stephen T. Worland,PhD
Market: NASDAQ
Listing Date: 01/08/2021
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist